» Articles » PMID: 21430083

Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2011 Mar 25
PMID 21430083
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We sought to define the prevalence of nonislet, organ-specific autoantibodies at diagnosis of type 1 diabetes and to determine the prevalence of comorbid autoimmune diseases.

Research Design And Methods: Children (n = 491) diagnosed with type 1 diabetes at the Barbara Davis Center for Childhood Diabetes were screened for autoimmune thyroid disease (thyroid peroxidase autoantibodies [TPOAb]), celiac disease (tissue transglutaminase autoantibodies [TTGAb]), and Addison disease (21-hydroxylase autoantibodies [21OHAb]).

Results: Of the 491 children, 161 had at least one nonislet autoantibody, and of these, 122 (24.8%) were positive for TPOAb, and 15 of the 122 (12.3%) had autoimmune thyroid disease. There were 57 (11.6%) who were positive for TTGAb, of whom 14 (24.6%) had celiac disease. Five (1.0%) were positive for 21OHAb, of whom one had Addison disease.

Conclusions: Many autoantibody-positive subjects present with additional autoimmune disorders. Detection of these autoantibodies at type 1 diabetes onset may prevent complications associated with delayed diagnosis of these disorders.

Citing Articles

The Prevalence of Autoimmune Diseases Among Children With Type I Diabetes Mellitus.

AlMoosa E, Al Ghadeer H, Alatiya J, Aldairam W, Alhamrani A, Alarbash A Cureus. 2025; 16(12):e76272.

PMID: 39845243 PMC: 11753791. DOI: 10.7759/cureus.76272.


4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S59-S85.

PMID: 39651988 PMC: 11635044. DOI: 10.2337/dc25-S004.


14. Children and Adolescents: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S283-S305.

PMID: 39651980 PMC: 11635046. DOI: 10.2337/dc25-S014.


Decreased prevalence and altered clinical phenotype of systemic sclerosis and other autoimmune connective tissue diseases in type 1 and type 2 diabetes: A cross-sectional observational study.

Abugharbyeh A, Khuder S, Kahaleh B J Scleroderma Relat Disord. 2024; :23971983241301231.

PMID: 39634481 PMC: 11613151. DOI: 10.1177/23971983241301231.


Evaluating the causal effects between Grave's disease and diabetes mellitus: a bidirectional Mendelian randomization study.

Zhang Y, Fu L Front Endocrinol (Lausanne). 2024; 15:1420499.

PMID: 39568808 PMC: 11576183. DOI: 10.3389/fendo.2024.1420499.


References
1.
Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G . Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab. 2006; 92(1):88-92. DOI: 10.1210/jc.2006-1494. View

2.
Bilimoria K, Pescovitz O, DiMeglio L . Autoimmune thyroid dysfunction in children with type 1 diabetes mellitus: screening guidelines based on a retrospective analysis. J Pediatr Endocrinol Metab. 2003; 16(8):1111-7. DOI: 10.1515/jpem.2003.16.8.1111. View

3.
Falorni A, Nikoshkov A, Laureti S, Grenback E, Hulting A, Casucci G . High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab. 1995; 80(9):2752-5. DOI: 10.1210/jcem.80.9.7673419. View

4.
Liu E, Li M, Bao F, Miao D, Rewers M, Eisenbarth G . Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children. J Pediatr. 2005; 146(4):494-9. DOI: 10.1016/j.jpeds.2004.11.028. View

5.
Barker J . Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006; 91(4):1210-7. DOI: 10.1210/jc.2005-1679. View